Target intelligence / Profile preview

Pseudomonas aeruginosa flagellar motility machinery (P. aeruginosa flagellum)

Target
P. aeruginosa flagellum
Molecular classification
Protein complex, Bacterial motor, Type III secretion system-related
01

Overview

The Pseudomonas aeruginosa flagellar motility machinery is a complex, multi-protein nanomachine that drives swimming and swarming motility, enabling the bacterium to navigate environments and colonize host tissues. It consists of a basal body anchored in the cell envelope, a hook, and a long extracellular filament composed of flagellin (FliC), powered by two distinct stator complexes, MotAB and MotCD (Lovewell et al., 2014; Gabrilska et al., 2024). Beyond locomotion, the flagellum serves as a critical virulence factor by facilitating initial attachment to surfaces and triggering host innate immune responses through Toll-like receptor 5 (TLR5) and the NLRC4 inflammasome (Lovewell et al., 2014). In clinical development, this machinery is targeted by anti-virulence strategies, such as monoclonal antibodies and vaccines, which aim to neutralize flagellin or inhibit motor function to prevent bacterial dissemination and biofilm formation (Saha et al., 2007). However, therapeutic intervention must account for the fact that P. aeruginosa often loses motility during chronic infections to evade phagocytic clearance and form antibiotic-tolerant aggregates (Gabrilska et al., 2024). Consequently, targeting the flagellar machinery is primarily relevant for acute infections or as a prophylactic measure to prevent the transition to a chronic, sessile state.

Other names
Flagellar apparatusFlagellar motorFlagellar assembly systemPolar flagellumFliCMotAB-MotCD complexFlagellar export apparatus
02

Mechanism of action

Inhibition of flagellar assembly, disruption of motor rotation, or neutralization of flagellin to prevent host cell attachment and TLR5-mediated inflammation.

03

Biological functions

Cell motilityChemotaxisAdhesionBiofilm formationInnate immune activation
04

Disease associations

InfectionCystic fibrosisPneumoniaSepsisBronchiectasis
05

Safety considerations

Selection for non-motile antibiotic-tolerant aggregatesEvasion of phagocytic clearanceImpact on commensal bacterial motility
06

Interacting drugs

Anti-flagellin monoclonal antibodies

2 more in the full profile.

07

Biomarkers

Flagellin (FliC) expressionBacterial swimming motilityTLR5 activation levelsNeutrophil elastase

Beyond the preview

Go deeper on Pseudomonas aeruginosa flagellar motility machinery (P. aeruginosa flagellum).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pseudomonas aeruginosa flagellar motility machinery (P. aeruginosa flagellum).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call